In English | En español
Questions About Cancer? 1-800-4-CANCER

NCI Drug Dictionary

  

tivozanib 
An orally bioavailable inhibitor of vascular endothelial growth factor receptors (VEGFRs) 1, 2 and 3 with potential antiangiogenic and antineoplastic activities. Tivozanib binds to and inhibits VEGFRs 1, 2 and 3, which may result in the inhibition of endothelial cell migration and proliferation, inhibition of tumor angiogenesis and tumor cell death. VEGFR tyrosine kinases, frequently overexpressed by a variety of tumor cell types, play a key role in angiogenesis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Synonym:oral VEGF receptor tyrosine kinase inhibitor AV-951
Code name:AV-951